Back to search results
NCT06542939

Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II)

Enrolling by Invitation
NAAges 21+InterventionalTreatment
NYU Langone Health
~450 participants
Updated 2025-11-28 on ClinicalTrials.gov
What's tested:Integrated CHW InterventionCHW Session 1 Only

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent of participants achieving BP control, defined as <130/80 mmHg
Measured over Month 6

Conditions

Diabetes Mellitus Type II
Hypertension

Explore related trials

HypertensionType 2 Diabetes Mellitus

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Nadia Islam, PhD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

identified as of South Asian ethnicity
at least 21 years of age
a diagnosis of diabetes
a diagnosis of hypertension
an uncontrolled BP reading (\>130/80mmHg) in the last 6 months

Exclusion

under the age of 21
Women who are pregnant
Type 1 diabetes or diabetes secondary to other conditions (e.g. steroid-induced, pancreatic insufficiency, or chemotherapy-induced)
inability to perform unsupervised physical activity

What this trial measures

  • Percent of participants achieving BP control, defined as <130/80 mmHgMonth 6

    The primary outcome will be the proportion of eligible patients at a practice site to achieve BP control (130/80 mmHg) at six months.